Ignite Creation Date:
2025-12-24 @ 2:10 PM
Ignite Modification Date:
2026-01-27 @ 9:42 AM
Study NCT ID:
NCT00004095
Status:
COMPLETED
Last Update Posted:
2017-04-18
First Post:
1999-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
Sponsor:
Northwestern University
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage IV colon cancer | View |
| None | stage IV breast cancer | View |
| None | recurrent breast cancer | View |
| None | recurrent non-small cell lung cancer | View |
| None | recurrent pancreatic cancer | View |
| None | stage IV rectal cancer | View |
| None | recurrent colon cancer | View |
| None | recurrent rectal cancer | View |
| None | stage IV renal cell cancer | View |
| None | recurrent renal cell cancer | View |
| None | extensive stage small cell lung cancer | View |
| None | recurrent small cell lung cancer | View |
| None | recurrent bladder cancer | View |
| None | stage IV bladder cancer | View |
| None | stage IV non-small cell lung cancer | View |
| None | stage IV pancreatic cancer | View |